|
M6PR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.493800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.495200E-03 |
| Normal-vs-Stage2 |
4.333200E-01 |
| Normal-vs-Stage3 |
4.906000E-01 |
| Normal-vs-Stage4 |
1.264950E-01 |
| Stage1-vs-Stage2 |
1.817780E-01 |
| Stage1-vs-Stage3 |
3.864400E-02 |
| Stage1-vs-Stage4 |
7.541200E-01 |
| Stage2-vs-Stage3 |
8.315000E-01 |
| Stage2-vs-Stage4 |
4.873600E-01 |
| Stage3-vs-Stage4 |
3.221000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.658030E-02 |
| Normal-vs-AfricanAmerican |
9.402000E-01 |
| Normal-vs-Asian |
4.277200E-01 |
| Caucasian-vs-AfricanAmerican |
1.039210E-01 |
| Caucasian-vs-Asian |
9.426800E-01 |
| AfricanAmerican-vs-Asian |
5.041200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.772200E-02 |
| Normal-vs-Female |
6.540300E-02 |
| Male-vs-Female |
7.900400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.418000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.380250E-02 |
| Normal-vs-Age(61-80Yrs) |
4.660200E-02 |
| Normal-vs-Age(81-100Yrs) |
6.954400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.104230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.751800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.213200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.413800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.730400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.148000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.760100E-02 |
| Normal-vs-Grade 2 |
1.086090E-02 |
| Normal-vs-Grade 3 |
9.514200E-02 |
| Normal-vs-Grade 4 |
5.835400E-01 |
| Grade 1-vs-Grade 2 |
7.986000E-01 |
| Grade 1-vs-Grade 3 |
5.449000E-01 |
| Grade 1-vs-Grade 4 |
2.717400E-01 |
| Grade 2-vs-Grade 3 |
2.459200E-01 |
| Grade 2-vs-Grade 4 |
2.008200E-01 |
| Grade 3-vs-Grade 4 |
5.575000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.704400E-03 |
| Normal-vs-ccB subtype |
5.850000E-02 |
| ccA subtype-vs-ccB subtype |
4.248600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.301300E-03 |
| Normal-vs-N1 |
2.603800E-01 |
| N0-vs-N1 |
6.908200E-01 |
|
|
